Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Colorectal Neoplasms

Free Subscription Articles published in Br J Surg Retrieve available abstracts of 96 articles: HTML format

Single Articles

September 2020
1. MA J, Whittaker Y, Chandran P
   Male Sexual Dysfunction after Pelvic Surgery for Colorectal Cancer.
   Br J Surg. 2020 Sep 8. doi: 10.1002/bjs.12033.
   PubMed    
   
   
   
2. LIYANAGE ASD, Gokul K, Babu BH, Ainsworth P, et al
   Stage migration of colorectal cancer during COVID-19 pandemic.
   Br J Surg. 2020 Sep 2. doi: 10.1002/bjs.11936.
   PubMed    
   
   
   
3. BARRETT K, Habib Bedwani N, Arya S, Bhargava A, et al
   Colorectal cancer referrals during the COVID-19 pandemic - a model for the faster diagnosis standard?
   Br J Surg. 2020 Sep 1. doi: 10.1002/bjs.12008.
   PubMed    
   
   
   August 2020
4. KONTOVOUNISIOS C
   The impact of the COVID-19 pandemic on colorectal cancer service provision.
   Br J Surg. 2020 Aug 28. doi: 10.1002/bjs.11990.
   PubMed    
   
   
   
5. BEHM KT, Grass F, Abd El Aziz MA, Kelley SR, et al
   Short term oncological outcomes of completely intracorporeal anastomosis after left sided robotic resections for colorectal cancer.
   Br J Surg. 2020 Aug 26. doi: 10.1002/bjs.11955.
   PubMed    
   
   
   
6. TREASURE T, Leonard P, Milosevic M, Williams NR, et al
   Pulmonary Metastasectomy in Colorectal Cancer: the PulMiCC randomised controlled trial.
   Br J Surg. 2020 Aug 21. doi: 10.1002/bjs.11948.
   PubMed    
   
   
   
7. DARVISH-DAMAVANDI M, Laycock J, Ward C, van Driel MS, et al
   An analysis of SARS-CoV-2 cell entry genes identifies the intestine and colorectal cancer as susceptible tissues.
   Br J Surg. 2020 Aug 10. doi: 10.1002/bjs.11911.
   PubMed    
   
   
   
8. MOHAMED F, Kallioinen M, Braun M, Fenwick S, et al
   Author response to: NICE Guidelines: management of colorectal cancer metastases.
   Br J Surg. 2020;107:e358.
   PubMed    
   
   
   July 2020
9. CARRANO FM, Foppa C, Carvello M, Spinelli A, et al
   With adequate precautions colorectal cancer surgery can be safely continued during COVID-19 pandemic.
   Br J Surg. 2020 Jul 31. doi: 10.1002/bjs.11859.
   PubMed    
   
   
   
10. CHAN DKH, Keh CHL, Seow CS, Iau PTC, et al
    Maintaining quality of care in colorectal cancer surgery during the COVID-19 pandemic.
    Br J Surg. 2020 Jul 31. doi: 10.1002/bjs.11866.
    PubMed    
    
    
    
11. MAEDA Y, Dunlop MG, Din FVN
    Risk mitigation for suspected colorectal cancer diagnostic pathway during COVID-19 pandemic.
    Br J Surg. 2020 Jul 23. doi: 10.1002/bjs.11798.
    PubMed    
    
    
    
12. BAUM M, Fallowfield L, Farewell V, Macbeth F, et al
    NICE Guidelines: management of colorectal cancer metastases.
    Br J Surg. 2020 Jul 11. doi: 10.1002/bjs.11789.
    PubMed    
    
    
    
13. MIRNEZAMI R, Knowles J, Kar A, Glynne-Jones R, et al
    Preoperative radiotherapy for locally advanced rectal cancer during and after the COVID-19 pandemic.
    Br J Surg. 2020;107:e263.
    PubMed    
    
    
    
14. GIANI I, Elbetti C, Trompetto M, Gallo G, et al
    Proctology in the COVID-19 era: handle with care.
    Br J Surg. 2020;107:e243.
    PubMed    
    
    
    June 2020
15. TUTTON MG
    Colorectal cancer surgery during the COVID-19 pandemic.
    Br J Surg. 2020 Jun 3. doi: 10.1002/bjs.11734.
    PubMed    
    
    
    
16. D'SOUZA N, Abulafi M
    Navigating the storm of COVID-19 for patients with suspected bowel cancer.
    Br J Surg. 2020;107:e204.
    PubMed    
    
    
    
17. LACY AM, De Lacy FB, Balibrea JM
    Considerations for transanal total mesorectal excision (TaTME) use during the COVID-19 pandemic.
    Br J Surg. 2020;107:e203.
    PubMed    
    
    
    May 2020
18. ALTAF K, Tan J, Parvaiz A, Ahmed S, et al
    Impact on colorectal cancer in COVID-19 pandemic.
    Br J Surg. 2020 May 29. doi: 10.1002/bjs.11720.
    PubMed    
    
    
    
19. 
    Colorectal cancer services during the COVID-19 pandemic.
    Br J Surg. 2020 May 22. doi: 10.1002/bjs.11706.
    PubMed    
    
    
    
20. MOHAMED F, Kallioinen M, Braun M, Fenwick S, et al
    Management of colorectal cancer metastases to the liver, lung or peritoneum suitable for curative intent: summary of NICE guidance.
    Br J Surg. 2020 May 9. doi: 10.1002/bjs.11609.
    PubMed    
    
    
    
21. DIAO YK, Liang L, Li C, Zhang CW, et al
    Is there a causal relationship between blood cultures after surgery for colorectal cancer and long-term oncological outcomes?
    Br J Surg. 2020;107:773.
    PubMed    
    
    
    April 2020
22. CULLINANE CM, Creavin B, O'Connell EP, Kelly L, et al
    Risk of colorectal cancer associated with BRCA1 and/or BRCA2 mutation carriers: systematic review and meta-analysis.
    Br J Surg. 2020 Apr 16. doi: 10.1002/bjs.11603.
    PubMed     Abstract available
    
    
    
23. KATAOKA K, Beppu N, Shiozawa M, Ikeda M, et al
    Colorectal cancer treated by resection and extended lymphadenectomy: patterns of spread in left- and right-sided tumours.
    Br J Surg. 2020 Apr 4. doi: 10.1002/bjs.11517.
    PubMed     Abstract available
    
    
    March 2020
24. CHAMBERS AC, Dixon SW, White P, Williams AC, et al
    Demographic trends in the incidence of young-onset colorectal cancer: a population-based study.
    Br J Surg. 2020 Mar 9. doi: 10.1002/bjs.11486.
    PubMed     Abstract available
    
    
    February 2020
25. KOBAYASHI M, Kako J, Kajiwara K, Oosono Y, et al
    Comment on: Predicting return to work among patients with colorectal cancer.
    Br J Surg. 2020;107:318.
    PubMed    
    
    
    January 2020
26. ALMAZEEDI S, El-Abd R, Al-Khamis A, Albatineh AN, et al
    Role of bariatric surgery in reducing the risk of colorectal cancer: a meta-analysis.
    Br J Surg. 2020 Jan 24. doi: 10.1002/bjs.11494.
    PubMed     Abstract available
    
    
    
27. SCHAAP DP, de Valk KS, Deken MM, Meijer RPJ, et al
    Carcinoembryonic antigen-specific, fluorescent image-guided cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer.
    Br J Surg. 2020 Jan 21. doi: 10.1002/bjs.11523.
    PubMed     Abstract available
    
    
    
28. SARASTE D, Jaras J, Martling A
    Population-based analysis of outcomes with early-age colorectal cancer.
    Br J Surg. 2020 Jan 10. doi: 10.1002/bjs.11333.
    PubMed     Abstract available
    
    
    
29. XU YJ, Sun X, Jiang H, Yin YH, et al
    Randomized clinical trial of continuous transversus abdominis plane block, epidural or patient-controlled analgesia for patients undergoing laparoscopic colorectal cancer surgery.
    Br J Surg. 2020;107:e133-e141.
    PubMed     Abstract available
    
    
    
30. RYAN EJ, O'Riordan JM, Winter DC
    Author response to: Comment on: Meta-analysis of the effect of extending the interval after long-course chemoradiotherapy before surgery in locally advanced rectal cancer.
    Br J Surg. 2020;107:151-152.
    PubMed    
    
    
    
31. HAJIBANDEH S, Hajibandeh S
    Comment on: Meta-analysis of the effect of extending the interval after long-course chemoradiotherapy before surgery in locally advanced rectal cancer.
    Br J Surg. 2020;107:151.
    PubMed    
    
    
    
32. WASMUTH HH, Faerden AE, Myklebust TA, Pfeffer F, et al
    Transanal total mesorectal excision for rectal cancer has been suspended in Norway.
    Br J Surg. 2020;107:121-130.
    PubMed     Abstract available
    
    
    
33. VAN DER SLUIS FJ, Couwenberg AM, de Bock GH, Intven MPW, et al
    Population-based study of morbidity risk associated with pathological complete response after chemoradiotherapy for rectal cancer.
    Br J Surg. 2020;107:131-139.
    PubMed     Abstract available
    
    
    December 2019
34. LARSEN SG, Pfeffer F, Korner H
    Author response to: Comments on: Norwegian moratorium on transanal total mesorectal excision.
    Br J Surg. 2019;106:1855.
    PubMed    
    
    
    
35. LACY AM, Nogueira ST, de Lacy FB
    Comment on: Norwegian moratorium on transanal total mesorectal excision.
    Br J Surg. 2019;106:1855.
    PubMed    
    
    
    November 2019
36. WATT SK, Fransgaard T, Degett TH, Thygesen LC, et al
    Associations between blood cultures after surgery for colorectal cancer and long-term oncological outcomes.
    Br J Surg. 2019 Nov 22. doi: 10.1002/bjs.11372.
    PubMed     Abstract available
    
    
    October 2019
37. DEN BAKKER CM, Anema JR, Huirne JAF, Twisk J, et al
    Predicting return to work among patients with colorectal cancer.
    Br J Surg. 2019 Oct 25. doi: 10.1002/bjs.11313.
    PubMed     Abstract available
    
    
    
38. ZABOROWSKI A, Stakelum A, Winter DC
    Author response to: Total neoadjuvant therapy in rectal cancer-improvement or overtreatment?
    Br J Surg. 2019;106:1558.
    PubMed    
    
    
    
39. MROCZKOWSKI P, Dziki L
    Total neoadjuvant therapy in rectal cancer - improvement or overtreatment?
    Br J Surg. 2019;106:1558.
    PubMed    
    
    
    August 2019
40. GARLIPP B, Gibbs P, Van Hazel GA, Jeyarajah R, et al
    Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trial.
    Br J Surg. 2019 Aug 19. doi: 10.1002/bjs.11283.
    PubMed     Abstract available
    
    
    
41. LARSEN SG, Pfeffer F, Korner H
    Norwegian moratorium on transanal total mesorectal excision.
    Br J Surg. 2019;106:1120-1121.
    PubMed    
    
    
    
42. PUCCIARELLI S, Del Bianco P, Pace U, Bianco F, et al
    Multicentre randomized clinical trial of colonic J pouch or straight stapled colorectal reconstruction after low anterior resection for rectal cancer.
    Br J Surg. 2019;106:1147-1155.
    PubMed     Abstract available
    
    
    
43. ERLANDSSON J, Pettersson D, Glimelius B, Holm T, et al
    Postoperative complications in relation to overall treatment time in patients with rectal cancer receiving neoadjuvant radiotherapy.
    Br J Surg. 2019;106:1248-1256.
    PubMed     Abstract available
    
    
    
44. BACHET JB, Moreno-Lopez N, Vigano L, Marchese U, et al
    BRAF mutation is not associated with an increased risk of recurrence in patients undergoing resection of colorectal liver metastases.
    Br J Surg. 2019;106:1237-1247.
    PubMed     Abstract available
    
    
    July 2019
45. ROTTIER SJ, van Dijk ST, van Geloven AAW, Schreurs WH, et al
    Meta-analysis of the role of colonoscopy after an episode of left-sided acute diverticulitis.
    Br J Surg. 2019;106:988-997.
    PubMed     Abstract available
    
    
    
46. LAKKIS Z, Vernerey D, Mege D, Faucheron JL, et al
    Morbidity and oncological outcomes of rectal cancer impaired by previous prostate malignancy.
    Br J Surg. 2019;106:1087-1098.
    PubMed     Abstract available
    
    
    
47. ZABOROWSKI A, Stakelum A, Winter DC
    Systematic review of outcomes after total neoadjuvant therapy for locally advanced rectal cancer.
    Br J Surg. 2019;106:979-987.
    PubMed     Abstract available
    
    
    
48. AMELUNG FJ, Borstlap WAA, Consten ECJ, Veld JV, et al
    Propensity score-matched analysis of oncological outcome between stent as bridge to surgery and emergency resection in patients with malignant left-sided colonic obstruction.
    Br J Surg. 2019;106:1075-1086.
    PubMed     Abstract available
    
    
    June 2019
49. BEDNARSKI BK, Nickerson TP, You YN, Messick CA, et al
    Randomized clinical trial of accelerated enhanced recovery after minimally invasive colorectal cancer surgery (RecoverMI trial).
    Br J Surg. 2019 Jun 19. doi: 10.1002/bjs.11223.
    PubMed     Abstract available
    
    
    
50. SILLO TO, Beggs AD, Morton DG, Middleton G, et al
    Mechanisms of immunogenicity in colorectal cancer.
    Br J Surg. 2019 Jun 19. doi: 10.1002/bjs.11204.
    PubMed     Abstract available
    
    
    
51. HAMID HKS
    Correspondence.
    Br J Surg. 2019;106:949-950.
    PubMed    
    
    
    
52. DUCHALAIS E, Larson DW
    Correspondence.
    Br J Surg. 2019;106:950-951.
    PubMed    
    
    
    
53. 
    Snapshot quiz.
    Br J Surg. 2019;106:836.
    PubMed    
    
    
    
54. QUIRAM BJ, Crippa J, Grass F, Lovely JK, et al
    Impact of enhanced recovery on oncological outcomes following minimally invasive surgery for rectal cancer.
    Br J Surg. 2019;106:922-929.
    PubMed     Abstract available
    
    
    May 2019
55. SHINKINS B, Primrose JN, Pugh SA, Nicholson BD, et al
    Serum carcinoembryonic antigen trends for diagnosing colorectal cancer recurrence in the FACS randomized clinical trial.
    Br J Surg. 2019;106:728.
    PubMed    
    
    
    
56. WESTBERG K, Palmer G, Hjern F, Holm T, et al
    Population-based study of surgical treatment with and without tumour resection in patients with locally recurrent rectal cancer.
    Br J Surg. 2019;106:790-798.
    PubMed     Abstract available
    
    
    
57. VAN DER POEL MJ, Barkhatov L, Fuks D, Berardi G, et al
    Multicentre propensity score-matched study of laparoscopic versus open repeat liver resection for colorectal liver metastases.
    Br J Surg. 2019;106:783-789.
    PubMed     Abstract available
    
    
    April 2019
58. REYNOLDS IS, Furney SJ, Kay EW, McNamara DA, et al
    Meta-analysis of the molecular associations of mucinous colorectal cancer.
    Br J Surg. 2019 Apr 4. doi: 10.1002/bjs.11142.
    PubMed     Abstract available
    
    
    
59. KEANE C, Park J, Oberg S, Wedin A, et al
    Functional outcomes from a randomized trial of early closure of temporary ileostomy after rectal excision for cancer.
    Br J Surg. 2019;106:645-652.
    PubMed     Abstract available
    
    
    March 2019
60. ABIS GSA, Stockmann HBAC, Bonjer HJ, van Veenendaal N, et al
    Randomized clinical trial of selective decontamination of the digestive tract in elective colorectal cancer surgery (SELECT trial).
    Br J Surg. 2019;106:355-363.
    PubMed     Abstract available
    
    
    
61. 
    Snapshot quiz.
    Br J Surg. 2019;106:341.
    PubMed    
    
    
    
62. KELLER DS, Reali C, Spinelli A, Penna M, et al
    Patient-reported functional and quality-of-life outcomes after transanal total mesorectal excision.
    Br J Surg. 2019;106:364-366.
    PubMed     Abstract available
    
    
    
63. LAU YC, Jongerius K, Wakeman C, Heriot AG, et al
    Influence of the level of sacrectomy on survival in patients with locally advanced and recurrent rectal cancer.
    Br J Surg. 2019;106:484-490.
    PubMed     Abstract available
    
    
    
64. VAN 'T SANT I, van Eden WJ, Engbersen MP, Kok NFM, et al
    Diffusion-weighted MRI assessment of the peritoneal cancer index before cytoreductive surgery.
    Br J Surg. 2019;106:491-498.
    PubMed     Abstract available
    
    
    
65. AHL R, Matthiessen P, Fang X, Cao Y, et al
    Effect of beta-blocker therapy on early mortality after emergency colonic cancer surgery.
    Br J Surg. 2019;106:477-483.
    PubMed     Abstract available
    
    
    February 2019
66. SEGELMAN J, Buchli C, Svanstrom Rojvall A, Matthiessen P, et al
    Effect of radiotherapy for rectal cancer on ovarian androgen production.
    Br J Surg. 2019;106:267-275.
    PubMed    
    
    
    January 2019
67. BJORNELV GMW, Dueland S, Line PD, Joranger P, et al
    Cost-effectiveness of liver transplantation in patients with colorectal metastases confined to the liver.
    Br J Surg. 2019;106:132-141.
    PubMed     Abstract available
    
    
    
68. ELFEKI H, Larsen HM, Emmertsen KJ, Christensen P, et al
    Bowel dysfunction after sigmoid resection for cancer and its impact on quality of life.
    Br J Surg. 2019;106:142-151.
    PubMed     Abstract available
    
    
    November 2018
69. KOSKENVUO L, Malila N, Pitkaniemi J, Miettinen J, et al
    Sex differences in faecal occult blood test screening for colorectal cancer.
    Br J Surg. 2018 Nov 21. doi: 10.1002/bjs.11011.
    PubMed     Abstract available
    
    
    August 2018
70. BARE M, Mora L, Tora N, Gil MJ, et al
    CCR-CARESS score for predicting operative mortality in patients with colorectal cancer.
    Br J Surg. 2018 Aug 13. doi: 10.1002/bjs.10956.
    PubMed     Abstract available
    
    
    
71. MARGONIS GA, Sasaki K, Gholami S, Kim Y, et al
    Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases.
    Br J Surg. 2018;105:1210-1220.
    PubMed     Abstract available
    
    
    
72. OKUNO M, Goumard C, Mizuno T, Kopetz S, et al
    Prognostic impact of perihepatic lymph node metastases in patients with resectable colorectal liver metastases.
    Br J Surg. 2018;105:1200-1209.
    PubMed     Abstract available
    
    
    May 2018
73. 
    Advanced colorectal cancer issue.
    Br J Surg. 2018;105:E240-E247.
    PubMed    
    
    
    
74. BROWN KGM, Solomon MJ
    Progress and future direction in the management of advanced colorectal cancer.
    Br J Surg. 2018;105:615-617.
    PubMed    
    
    
    
75. PASSOT G, Dumont F, Goere D, Arvieux C, et al
    Multicentre study of laparoscopic or open assessment of the peritoneal cancer index (BIG-RENAPE).
    Br J Surg. 2018;105:663-667.
    PubMed     Abstract available
    
    
    
76. YAMASHITA S, Chun YS, Kopetz SE, Vauthey JN, et al
    Biomarkers in colorectal liver metastases.
    Br J Surg. 2018;105:618-627.
    PubMed     Abstract available
    
    
    
77. 
    Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer.
    Br J Surg. 2018;105:650-657.
    PubMed     Abstract available
    
    
    April 2018
78. QUYN AJ, Fraser CG, Rodger J, Digan A, et al
    Participation in bowel screening among men attending abdominal aortic aneurysm screening.
    Br J Surg. 2018;105:529-534.
    PubMed     Abstract available
    
    
    March 2018
79. SHINKINS B, Primrose JN, Pugh SA, Nicholson BD, et al
    Serum carcinoembryonic antigen trends for diagnosing colorectal cancer recurrence in the FACS randomized clinical trial.
    Br J Surg. 2018 Mar 26. doi: 10.1002/bjs.10819.
    PubMed     Abstract available
    
    
    
80. DUELAND S, Foss A, Solheim JM, Hagness M, et al
    Survival following liver transplantation for liver-only colorectal metastases compared with hepatocellular carcinoma.
    Br J Surg. 2018 Mar 13. doi: 10.1002/bjs.10769.
    PubMed     Abstract available
    
    
    
81. VAN ZOGGEL DMGI, Bosman SJ, Kusters M, Nieuwenhuijzen GAP, et al
    Preliminary results of a cohort study of induction chemotherapy-based treatment for locally recurrent rectal cancer.
    Br J Surg. 2018;105:447-452.
    PubMed     Abstract available
    
    
    February 2018
82. PARK J, Danielsen AK, Angenete E, Bock D, et al
    Quality of life in a randomized trial of early closure of temporary ileostomy after rectal resection for cancer (EASY trial).
    Br J Surg. 2018;105:244-251.
    PubMed     Abstract available
    
    
    
83. GRUT H, Solberg S, Seierstad T, Revheim ME, et al
    Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases.
    Br J Surg. 2018;105:295-301.
    PubMed     Abstract available
    
    
    January 2018
84. ESCAL L, Nougaret S, Guiu B, Bertrand MM, et al
    MRI-based score to predict surgical difficulty in patients with rectal cancer.
    Br J Surg. 2018;105:140-146.
    PubMed     Abstract available
    
    
    
85. UBINK I, van Eden WJ, Snaebjornsson P, Kok NFM, et al
    Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases.
    Br J Surg. 2018;105:e204-e211.
    PubMed     Abstract available
    
    
    
86. MARKS KM, West NP, Morris E, Quirke P, et al
    Clinicopathological, genomic and immunological factors in colorectal cancer prognosis.
    Br J Surg. 2018;105:e99-e109.
    PubMed     Abstract available
    
    
    
87. RYAN EJ, Creagh EM
    Emerging methods in colorectal cancer screening.
    Br J Surg. 2018;105:e16-e18.
    PubMed    
    
    
    
88. GAINES S, Shao C, Hyman N, Alverdy JC, et al
    Gut microbiome influences on anastomotic leak and recurrence rates following colorectal cancer surgery.
    Br J Surg. 2018;105:e131-e141.
    PubMed     Abstract available
    
    
    
89. KOYAMA FC, Lopes Ramos CM, Ledesma F, Alves VAF, et al
    Effect of Akt activation and experimental pharmacological inhibition on responses to neoadjuvant chemoradiotherapy in rectal cancer.
    Br J Surg. 2018;105:e192-e203.
    PubMed     Abstract available
    
    
    December 2017
90. WESTBERG K, Palmer G, Hjern F, Nordenvall C, et al
    Population-based study of factors predicting treatment intention in patients with locally recurrent rectal cancer.
    Br J Surg. 2017;104:1866-1873.
    PubMed     Abstract available
    
    
    November 2017
91. CREAVIN B, Kelly ME, Ryan E, Winter DC, et al
    Meta-analysis of the impact of surgical approach on the grade of mesorectal excision in rectal cancer.
    Br J Surg. 2017;104:1609-1619.
    PubMed     Abstract available
    
    
    
92. DIEDEREN K, Sahami SS, Tabbers MM, Benninga MA, et al
    Outcome after restorative proctocolectomy and ileal pouch-anal anastomosis in children and adults.
    Br J Surg. 2017;104:1640-1647.
    PubMed     Abstract available
    
    
    October 2017
93. NITSCHE U, Stoss C, Stecher L, Wilhelm D, et al
    Meta-analysis of outcomes following resection of the primary tumour in patients presenting with metastatic colorectal cancer.
    Br J Surg. 2017 Oct 31. doi: 10.1002/bjs.10682.
    PubMed     Abstract available
    
    
    
94. ELLEBAEK SB, Fristrup CW, Hovendal C, Qvist N, et al
    Randomized clinical trial of laparoscopic ultrasonography before laparoscopic colorectal cancer resection.
    Br J Surg. 2017;104:1462-1469.
    PubMed     Abstract available
    
    
    February 2017
95. MARTLING A, Smedby KE, Birgisson H, Olsson H, et al
    Risk of second primary cancer in patients treated with radiotherapy for rectal cancer.
    Br J Surg. 2017;104:278-287.
    PubMed     Abstract available
    
    
    
96. HAIN E, Maggiori L, Manceau G, Mongin C, et al
    Oncological impact of anastomotic leakage after laparoscopic mesorectal excision.
    Br J Surg. 2017;104:288-295.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: